2025 ASTRO Annual Meeting

UPMC Hillman Cancer Center will be well-represented at ASTRO 2025 in San Francisco, CA.

Sunday, September 28

SS 06: GYN 1: Radiation and Cancer Biology 1: Factors Mediating Radioresistance
2:30pm– 3:45pm PT | Room 155/157
Discussant: 3:30pm – 3:40pm PT
Yvonne Mowery, MD, PhD, BS

PQA 01 - Radiation and Cancer Physics, Sarcoma and Cutaneous Tumors
2278 - Comparison of Single Time Point Radiopharmaceutical Therapy Dosimetry Results from Various Commercial Dosimetry Software Packages
2:30pm – 4:00pm PT | Hall F | Screen 17
Edmond Yaghoubian, MD

Monday, September 29

PQA 03 - Central Nervous System, Professional Development/Medical Education
2556 - Repeat Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Local Control and Toxicity
8:00am – 9:00am PT | Hall F | Screen 28
Serah Choi, MD, PhD

PQA 03 - Central Nervous System, Professional Development/Medical Education
2630 - Memory Circuit Dosimetry in Patients Treated with SRS for Brain Metastases
8:00am – 9:00am PT | Hall F | Screen 28
Nina Lo, MS, BS

PQA 03 - Central Nervous System, Professional Development/Medical Education
2667 - Photon-Based Stereotactic Radiosurgery-Style Planning for the Treatment of Primary Brain Tumors to Reduce Radiation Dose to the Uninvolved Brain
8:00am – 9:00am PT | Hall F | Screen 28
Joseph Shields, MS
Serah Choi, MD, PhD

PQA 04 - Gynecological Cancer, Head and Neck Cancer
2842 - Salivary Gland Cancer Patterns of Failure after Radiotherapy
10:45am – 12:00pm PT | Hall F | Screen 1
Jeffrey Shogan, DO

PQA 04 - Gynecological Cancer, Head and Neck Cancer
2754 - What is the Optimal Fractionation for Image-Based High-Dose-Rate Brachytherapy Boost in Medically Inoperable Endometrial Cancer: 4 vs. 5 Fractions?
10:45am – 12:00pm PT | Hall F | Screen 1
Abigail Groszkiewicz, MD

EDU 21 - Leveraging Anti-Tumor Immunity with Radiopharmaceutical Therapy (RPT) and Potential Combinatorial Approaches with RPT and Immunotherapy
10:45am – 12:00pm PT | Room 305/306/309
Immune-based Mechanism of RPT and Potential Synergies with Immunotherapy (and/or EBRT)
11:17am – 11:32am PT | Room 305/306/309
Ravi Patel, MD, PhD

ST 01 - Radiotherapy in Conflict Zones: Stories of Struggles, Resilience and Hope
10:45am – 12:00pm PT | Room 314
Panel Reflection: Connecting Threads
11:45am – 11:50am PT
Sarah Ashmeg, PhD, DABR

Luncheon 01 - Women of ASTRO Luncheon - Safe at Work: Implementing Effective
Strategies to Address Harassment in the Radiation Oncology Workplace
12:00pm – 1:00pm PT | Room 24
Practical Strategies Implemented by Societies to Foster an Environment Free of Harassment
12:15pm – 12:30pm PT | Room 24
Parul Barry, MD

EDU 25 - Multidisciplinary Lung Cancer Tumor Board: A Case-Based Discussion
Spanning Bread-and-Butter through the Gray Zone
Introductions: 3:00pm – 4:00pm PT | Room 20/21
Questions and Answers: 3:47pm – 4:00pm PT
Neal McCall, MD

PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement
3056 - Effect of Sex on Limosilactobacillus Reuteri Releasing IL-22 (LR-IL-22) Mitigation of Gastrointestinal-Acute Radiation Syndrome
5:00pm – 6:00pm PT | Hall F | Screen 3
Diala Hamade, MD

PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement
3113 - Inhibition of de novo Lipogenesis through Acly and FASN Sensitizes PDAC to RT and Ferroptosis
5:00pm – 6:00pm PT | Hall F | Screen 3
Adam Mueller, MD, PhD

PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement
3048 - Quercetin, A Natural Flavonoid Compound, Sensitizes Pancreatic Ductal Adenocarcinoma to Radiation Therapy
5:00pm – 6:00pm PT | Hall F | Screen 3
Vishwa Gandhi, PhD, MS

SS 28 - GU 6: Revelations in Renal Radiotherapy
Speaker: 5:00pm – 6:00pm PT | Room 301-304
Adam Olson, MD, MS

EDU 30 - Management of Locally Recurrent Head and Neck Cancer
5:00pm – 6:00pm PT | Room 310-312
The Role of Systemic Therapy for Locally Recurrent Squamous Cell Carcinoma of the Head and Neck in the Setting of Prior Radiation Therapy
5:17pm – 5:32pm PT | Room 310-312
Dan Zandberg, MD

Tuesday, September 30

SS 38 - Radiation and Cancer Biology 4: Immunometabolism
Speaker: Radiation and Cancer Biology 4: Immunometabolism
12:45pm – 2:00pm PT | Room 156/158
Adam Mueller, MD, PhD

PQA 07 - Genitourinary Cancer, Patient Safety, Nursing/Supportive Care
3190 - Impact of Bladder Filling on External Beam Radiotherapy for Prostate Cancer: A Mixed-Methods Analysis in a Large, Integrated Cancer Network
12:45pm – 2:00pm PT | Hall F | Screen 34
Diala Hamade, MD

PQA 07 - Genitourinary Cancer, Patient Safety, Nursing/Supportive Care
3371 - Predictors of PSA Response and Hematologic Changes in Patients Undergoing Lu-177-PSMA-617 Radiopharmaceutical Therapy: A Multivariate Analysis
12:45pm – 2:00pm PT | Hall F | Screen 34
Edmond Yaghoubian, MD

EDU 39 - Update on ASTRO/ASCO/SSO Postmastectomy Radiation Therapy Guideline:
A Case-Based Interactive Discussion
12:45pm – 2:00pm PT | Room 24
Case 3: Options for Dose/Fractionation
1:17pm – 1:32pm PT | Room 24
Parul Barry, MD

SS 37 - Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us
12:45pm – 2:00pm PT | Room 314
316 - High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab +/- Docetaxel in Previously-Irradiated HNSCC
1:25pm – 1:35 PT | Room 314
Alberto Vera, MD

PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care
3533 - Durable Clinical Response Following Radiosurgery for Trigeminal Neuralgia is Predicted by Volumetric Dose Distribution to the Cisternal Portion of the Nerve
2:30pm – 3:45 PT | Hall F | Screen 25
Muhammed Shohayeb, MD, MBChB

PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care
3516 - Endobronchial HDR Brachytherapy for Post-Transplant or Wegener's Granulomatosis Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function, Subsequent Procedures, and Second Malignancy
2:30pm – 3:45 PT | Hall F | Screen 25
Abigail Groszkiewicz, MD

EDU 47 - Neoadjuvant Immunotherapy in Head and Neck Cancer, Sarcoma and Cutaneous Malignancies
2:30pm – 3:45 PT | Room 160
Neoadjuvant Immune Therapy in Head and Neck Cancer
2:47pm – 2:57pm PT | Room 160
Kevin Contrera, MD

EDU 47 - Neoadjuvant Immunotherapy in Head and Neck Cancer, Sarcoma and Cutaneous Malignancies
2:30pm – 3:45pm PT | Room 160
Neoadjuvant Immune Therapy in Sarcoma
3:12pm – 3:27pm PT | Room 160
Yvonne Mowery, MD, PhD, BS

EDU 51 - The Role of Radiotherapy in the Management of Non-Malignant Diseases of the Head and Neck
4:00pm – 5:00pm PT | Room 159
Dose and Volume Selection for Benign Tumors of the Head and Neck
4:02pm – 4:17pm PT | Room 159
Christopher Wilke, MD, PhD

SS 42 - Gyn 4: GYN Clinical Trials - Challenging the Paradigm in Gynecologic Cancers
Moderator: 4:00pm – 5:00pm PT | Room 156/158
Parul Barry, MD

Wednesday, October 1

SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer
10:30am – 11:45am PT | Room 154

359 - Hallmark Interferon-Alpha Response Analysis in Localized Prostate Cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, 9902, 0126, and 0521 Clinical Trials
10:50am – 11:00am PT | Room 154
Adam Olson, MD, MS

QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions
10:30am – 11:30am PT | Room 159

1142 - Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation
10:55am – 11:00am PT | Room 159
Brian Leibowitz, PhD